| Agency for Healthcare Research & Quality (AHRQ) |
Novel, High-Impact Studies Evaluating Health System & Healthcare Professional Responsiveness to COVID-19 (RFA-HS-20-003) |
$1,000,000 |
6/15/2020 |
| Competitive Revision Supplements to Existing AHRQ Patient Centered Outcomes Research (PCOR) Grants & Cooperative Agreements to Evaluate Health System & Healthcare Professional Responsiveness to COVID-19 (PA-20-072) |
Budget depends on mechanism type (see RFA) |
LOI 5/29/2020 |
| Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants & Cooperative Agreements to Evaluate Health system & Healthcare Professional Responsiveness to COVID-19 (PA-20-70) |
Budget depends on mechanism type (see RFA) |
LOI 5/29/2020 |
| New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (NOT-HS-20-008) |
R01 equivalent |
expected June 2020 |
| Amazon Web Services (AWS) |
AWS Diagnostic Development Initiative (DDI) |
budget must reflect needs (up to $20M available) |
6/30/2020 |
| American diabetes Association (ADA) |
The American Diabetes Association COVID-19 and Diabetes Research Award |
$100,000 |
5/22/2020 |
| American Heart Association |
Rapid Response Grant COVID-19 and Its Cardiovascular Impact |
$100,000
(coordinating center $150,000) |
4/6/2020 |
| American Lung Association |
COVID-19 and Emerging Respiratory Viruses Research Award |
$200,000 |
5/30/2020 |
| AXA Research Fund |
Exceptional Flash Call for Proposals: Mitigating risk in the wake of the COVID-19 Pandemic |
£250,000 |
5/1/2020 |
| Biomedical Advanced Research & Development Authority (BARDA) |
BARDA Broad Agency Announcement |
negotiated after white paper submission |
10/31/2020 |
| Booz Allen Foundation |
Booz Allen Foundation Innovation Grant |
$100,000 |
6/5/2020 |
| Centers for Disease Control (CDC)
|
Annual Estimates of Influenza Vaccine Effectiveness for Preventing Medically Attended Laboratory-Confirmed Influenza in the United States (RFA-IP-21-005)
|
$2,150,000 |
1/8/2021
|
|
Strengthening Public Health Systems & Services through National Partnerships to Improve & Protect the Nation's Health
|
$3,000,000 |
3/20/2020
(anticipated)
|
|
Applied Research Address the Coronavirus (COVID-19) Emerging Public Health Emergency
|
|
3/25/2020
(call for white papers) |
| Coalition of Epidemic Preparedness Innovations (CEPI) |
COVID-19 Vaccine Development & Production
|
unspecified |
accepted through 6/30/2020 |
| COVID-19 Early Treatment Fund (CEFT) |
Funding for Outpatient Trials
|
up to $1,000,000 |
currently accepting applications |
|
Department of Defense (DoD)
|
Newton Award for Transformative Ideas during the COVID-19 Pandemic (BRO-20-Newton)
|
$100,000 |
5/15/2020 |
|
XTech COVID-19 Ventilator Challenge
|
White Paper $5,000
Application $100,000 |
4/5/2020 - 5/31/2020 |
|
Request for Information for PPE in response to COVID-19
|
N/A |
3/24/2020
(information accepted on a rolling basis) |
|
Prototype Development to Combat Novel Coronavirus Disease COVID-19
|
TBD |
4/15/2020 |
| Department of Energy (DOE) |
Soliciting input to COVID-19 response
|
DOE Resources |
Rolling |
| Department of State |
COVID-19 Small Grants Program Mission to India (ND-NOFO-20-111)
|
$100,000 |
9/30/2020 |
|
US Embassy Abuja COVID 19 Response (DOS-NGA-PD-ABV-FY20-005)
|
$50,000 |
May 1,2020 |
| Disability Inclusion Fund |
COVID-19 Rapid Response Fund
|
$15,000 |
5/6/2020 |
| Emergency Medicine Foundation (EMF) |
Fujifilm SonoSite COVID-19 Point of Care Ultrasound Acceleration Research Grant
|
up to $90,000 |
8/21/2020 |
| Encephalitis Society |
Encephalitis & COVID-19 Seed Funding
|
£10,000 |
8/31/2020 |
| Environmental Protection Agency (EPA) |
Removal Emergency Response Program (EPA-OLEM-19-08)
|
$500,000
(5% cost share required) |
6/10/2020 |
| Ferring Pharmaceuticals |
Ferring COVID-19 Investigational Grants
|
€25,000 |
4/15/2020 (accepted through 10/31/2020) |
| Genentech |
2020 Health Equity Innovations Fund
|
$750,000 |
LOI: 8/10/2020
Full invited app: 10/15/2020 |
| Gilead |
COVID-19 RFP Program: COMMIT
|
$250,000 |
ends 8/3/2020 |
| Harrington Discovery Institute |
Harrington Scholar Award for Coronavirus
|
$150,000 |
4/30/2020 |
| IBM XPRIZE |
2020 COVID-19 Call for Code Global Challenge
|
$270,000 |
7/31/2020 |
| Indo-US Science & Technology Forum (IUSSTF) |
Indo-US Virtual Networks for COVID-19
|
$66,000 |
5/15/2020 |
| Internet Society Foundation |
Emergency Response Grant Programme: COVID-19
|
$500,000 |
5/17/2020 |
| IBSA Foundation for Scientific Research |
The IBSA Foundation Fellowships
|
€30,000 |
12/31/2020 |
| LifeArc |
Coronavirus therapeutics: Call for Rapid Deployment for the development and testing of therapeutics to treat COVID-19
|
£10,000,000 |
4/6/2020 |
| Johnson & Johnson Innovation - JLABS |
DR-TB Lifeline Design Quickfire Challenge
|
$50,000 |
5/19/2020 |
| Medical CBRN Defense Consortium (MCDC) |
Prototype Development to Combat Coronavirus (COVID-19)
|
undetermined |
pre-announcement |
|
RFI CoV Pandemic Response
|
undetermined |
3/19/2020-5/21/2020
(call for rapid response white papers)
|
| Leveraging STRIDES for Cloud Computing Activities in Common Fund Awards (NOT-RM-20-009) |
Cloud Computing support >$10,000 |
beginning 4/1/2020 |
| Merck KGaA (Germany) |
Research Grant for Pandemic Preparedness |
£1,500,000 |
rolling basis |
| Mozilla |
COVID-19 Solutions Fund |
$50,000 |
rolling basis |
| National Institutes of Health |
Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (PAR-20-243) |
up to $750,000 DC/year |
8/20/2020, 12/2/2020, 3/2/2021 |
| NOSI: Select Research Areas for Severe Acute Respiratory Syndrome 2 and Coronavirus Disease 2019 (NOT-AI-20-051) |
varies |
6/16/2020-9/7/2021 |
| Supplements for Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System (NOT-NS-20-051) |
$200,000 |
rolling thru 4/14/2021 |
| NOSI: Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations (NOT-OD-20-120) |
no more than $700,000 |
7/8/2020 - 9/20/2020 |
| NOSI: Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations (NOT-OD-20-121) |
no more than $3,500,000 |
8/7/2020 |
| NOSI: Administrative Supplements & Urgent Competitive Revisions for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19) (NOT-AT-20-012) |
$150,000 |
5/22/2020-8/17/2020 (NCCIH grants) |
| NOSI: Administrative supplements to Existing NIH ECHO cooperative Agreements for COVID-19 related research (NOT-OD-20-107) |
$200,000 |
6/22/2020 |
| NOSI: Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & COVID-19 (NOT-RM-20-015) |
may not exceed parent award |
through 6/19/2020 |
| NOSI: Emergency Competitive Revisions on COVID-19 for Currently Active NHLBI Phase I-III Clinical Trials (NOT-HL-20-782) |
up to 2 years support |
through 10/5/2020 |
| RFI: Strategy for Research in Coronavirus Serology Testing & Serological Sciences (NOT-CA-20-065) |
NCI RFI |
5/26/2020 |
| NIH Tech Accelerator Challenge 2020 |
$500,000 (top prize) |
6/2/2020 |
| Novel, High-Impact Studies Evaluating Health system & Healthcare Professional Responsiveness to COVID-19 (R01) (RFA-HS-20-003) |
$1,000,000 |
6/15/2020 |
| NOSI: Data Driven Research on Coronavirus Disease 2019 (R21) (NOT-LM-20-011) |
$275,000 |
6/16/2020 |
| Supplements for Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System (NOT-NS-20-051) |
$200,000 |
until 4/14/2021 |
| Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 & COVID-19 (R21) (PAR-20-177) |
$275,000 |
until 4/30/2021 |
| Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 & COVID-19 (R01) (PAR-20-178) |
budget must reflect need |
until 4/30/2021 |
| NOSI: Urgent Competitive Revisions & Administrative Supplements for Coronavirus disease 2019 (NOT-DE-20-22) |
may not exceed $150,000 |
6/1/2020, 11/2/2020 |
| Rapid Acceleration of Diagnostics (RADx) |
up to $500,000,000 |
Rolling |
| NOSI: Administrative Supplements & Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral & Social Sciences(NOT-OD-20-097) |
$200,000 |
4/13/2020 - 3/31/2021 |
| NOSI: NCI Urgent Competitive Revision & Administrative Supplements on Coronavirus Disease (NOT-CA-20-042) |
$100,000 |
4/14/2020 - 6/26/2020 |
| NIEHS Worker Training Program Coronavirus & Infectious Disease Response Training (NOT-ES-20-017) |
$200,000 |
4/24/2020 |
| NOSI: Competitive & Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health & Health Disparities (NOT-ES-20-019) |
$125,000 |
5/1/2020 - 5/1/2021 |
| NOSI: NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (NOT-ES-20-020) |
must reflect need |
5/1/2020, 6/1/2020, (other deadlines...) |
| NOSI: Urgent Competitive Revisions to Accelerate Research on the Development of Predictive Models of the Spread of SARS-CoV-2 and Outcomes of Potential Public Health Interventions on COVID-19 (NOT-GM-20-027) |
one year; no greater than current parent award |
5/5/2020 |
| NOSI: Administrative Supplements & Competitive Revision Supplements on Coronavirus Disease 2019 (NOT-AA-20-011) |
$200,000 within mission of NIAAA |
5/15/2020 - 4/15/2021 |
| NOSI: Emergency Competitive Revisions to Existing NIH Grants & Cooperative Agreements for Tissue chips Research on the 2019 Novel Coronavirus (NOT-TR-20-017) |
limited to amount of current parent award |
5/15/2020 - 1/25/2022 |
| NOSI: Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus (NOT-TR-20-016) |
no more than 25% of total costs of current award |
5/15/2020 - 1/25/2022 |
| NOSI: Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (NOT-DC-20-004) |
$125,000 |
6/1/2020 |
| NOSI: Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (NOT-DK-20-018) |
limited to current year budget within mission of NIDDK |
6/1/2020 |
| NOSI: Urgent Competitive Revision Supplements on Coronavirus Disease 2019 Related to HIV Comorbidities, Coinfections, and Complications (NOT-DK-20-020) |
limited to current year budget within mission of NIDDK |
6/1/2020 |
| NOSI: Administrative Supplements for Research on Coronavirus Disease 2019 (NOT-LM-20-010) |
$75,000 |
6/1/2020 |
| NOSI: Development of Biomedical Technologies for Coronavirus Disease 2019 (NOT-EB-20-007) |
varies, check RFA |
6/5/2020, 6/16/2020 |
| Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations, R01 Clinical Trial Optional (PA-20-172) |
not limited, multiple institutes |
10/5/2020 (and standard R01 deadlines) |
| NOSI: Emergency Competitive Revision & Supplements on Biomedical Technologies for Coronavirus Disease 2019 (NOT-EB-20-008) |
up to amount of current award |
rolling, ends 11/10/2020 |
| NOSI: Availability of Administrative Supplements and Urgent Competitive Revision for Mental Health Research Monte 2019 Novel Coronavirus (NOT-MH-20-047) |
contact program officer(s) |
rolling basis through 4/15/2021 |
| Urgent Competitive Revision to Existing NIH Grants & Cooperative Agreements (Urgent Supplement-Clinical Trial Optional)(PA-18-935) |
must reflect needs (multiple institutes) |
Varies by awarding IC |
| NOSI: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease (COVID-19) (NOT-AI-20-31) |
Check RFA(s) |
4/5/2020 (deadlines through 4/5/2021) |
| NOSI: NIA Availability of Administrative Supplements & Revision Supplements on Coronavirus Disease 2019 (COVID-19) (NOT-AG-20-022) |
must reflect needs |
4/6/2020 (applications accepted through 5/1/2021) |
| NOSI: Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (NOT-TR-20-012) |
Applications to:
PAR-17-465
PAR-18-462
PAR-18-332 |
6/5/2020 (& other later deadlines) |
| Partnerships for Countermeasures against Select Pathogens (R01)(RFA-AI-20-028) |
$4,050,000 |
6/29/2020
Clinical Trials not Allowed |
| Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement-Clinical Trial Optional) (pa-20-135) |
Not limited |
See notice of special interest by IC
NCI, NCCIH, NHGRI, NIAID, NICHD, NIDDK, NIEHS, NIGMS, NIMHD, NIBIB |
| Administrative Supplement NIAID |
no limit |
2/6/2020
(applications accepted through 2/6/2021) |
| NOSI Regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 (NOT-GM-20-025) |
not greater than parent award and reflective of actual need |
3/5/2020
(applications accepted through 2/5/2021) |
| Collaborative Cross Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21) (PAR-18-781) |
$275,000 |
9/9/2020 |
| Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (NOT-DA-20-047) |
no limit |
3/19/2020-3/31/2020 |
| Notice of Special Interest (NOSI) Regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCOV)(NOT-AI-20-30) |
No limit |
2/6/2021
(rolling basis) |
| NOSI: Availability of Administrative Supplements & Revision Supplements on Coronavirus Disease 2019 (COVID-19) (NOT-HL-20-757) |
not specified |
3/17/2020 - 10/5/2020
(rolling basis) |
| Administrative Supplements to existing NIH Grants & Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) |
No limit |
Differs - check with Institutes/Centers |
| Partnerships for Countermeasures Against Select Pathogens (R01 Clinical Trials not Allowed) |
$3,750,000 |
6/29/2020 |
| Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) |
No limit |
5/13/2020, 9/13/2020, see RFA for additional deadlines |
| National Science Foundation (NSF) |
 Future of International Research Collaboration Post COVID-19 |
up to $200,000 |
now through 03/21/2021 |
| RAPID: Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) |
$200,000 |
check with program officers for eligibility |
| Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) |
$200,000 (RAPID) & supplemental funding requests |
check with program officers for eligibility |
| Office of Management & Budget (OMB) |
Administrative Relief for Recipients & Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations (M-20-17) |
unspecified |
effective immediately |
| Patient-Centered Outcomes Research Institute (PCORI) |
Phased Large Awards for Comparative Effectiveness Research - Cycle 3 2020 |
>$10,000,000 |
LOI: 9/29/2020
Full apps: 1/12/2021 |
| Eugene Washington PCORI Engagement Award Special Cycle: Supporting Engagement in and Dissemination of PCOR/CER in the Context of COVID-19 |
$150,000 |
5/22/2020 |
| COVID-19 Targeted PFA |
$500,000 |
5/26/2020 |
| COVID-19 Related Enhancements to Existing PCORI-Funded Research Projects |
$500,000 |
rolling basis |
| COVID-19 Related Enhancements to Existing PCORI-Funded Engagement Awards |
$150,000 |
rolling basis |
| PCORI New Research Studies, Implementation and Engagement Projects COVID-19 commitment |
$60,000,000 |
just released |
| Pfizer |
Vaccine Preventable Diseases - COVID-19 Competitive Grant Program |
$50,000-$250,000 |
6/17/2020 |
| COVID-19: Continuity in Care for Patients with Metastatic Breast Cancer Grant Support Program |
$250,000 |
5/21/2020 |
| COVID-19 Competitive Grant Program |
$250,000 |
5/22/2020 |
| Robert Wood Johnson Foundation |
Emergency Response for the Health Care System: Innovation Challenge |
$1,000-$25,000 |
Phase 1: 6/12/2020
Phase 2: 8/18/2020 |
| Systems for Action: supplemental Research on COVID-19 Response & Recovery |
up to $100,000 |
8/5/2020 |
| Emergency Response for the General Public: Innovation Challenge |
$1,000-$25,000 |
Phase 1: 6/12/2020
Phase 2: 8/18/2020 |
| Pioneering Ideas: Exploring the Future to Build a Culture of Health |
averages $315,000 |
Open |
| Russell Sage Foundation |
Social, Political, Economic, or Psychological Disruptions that Affect Social & Living Conditions in the US |
$175,000 |
5/21/2020 |
| Society for Academic Emergency Medicine (SAEMF) |
SAEMF COVID-19 Research Grant |
$5,000-$25,000 |
6/1/2020 |
| Stevens Initiative |
Stevens Initiative Coronavirus Response Fund |
$20,000 - $100,000 |
6/12/2020 |
| The Rheumatology Research Foundation |
Scientist Development Award, Investigator Award, & Innovative Research Award |
varies |
LOI: 6/1/2020
Full: 7/1/2020 |
| Innovative Research for Community Practitioners |
$400,000 |
LOI: 6/1/2020
Full: 8/3/2020 |
| Twenty-three and Me |
23 and Me Research Innovation Collaborations Program |
access to deidentified databases |
6/12/2020 |
| Tracelink |
COVID-19 Relief and Support Grants |
$1,000,000 (available) |
5/15/2020 |
| United Nations Development Programme Centre for Technology, Innovation, & Sustainable Development |
COVID-19 Detect & Protect Challenge for Solutions in Developing Countries |
$25,000 |
6/30/2020 |
| UNMC Internal Opportunities |
GP-IDeA-CTR COVID-19 risk in individuals with underlying medical conditions and Impact of the COVID-19 pandemic on palliative care practice |
unspecified |
on-going |
| UNMC Nebraska Neuroscience Alliance COVID-19 Rapid Response Grants |
$80,000 available |
5/18/2020 |
| College of Medicine COVID-19 Rapid Response Grants |
up to $100,000 |
5/4/2020 |
| ViiV Healthcare |
HIV & COVID-19: RFP for Research Projects to Help Improve the Understanding and Management of COVID-19 in PLHIV |
£250,000 |
5/18/2020 |
| Wellcome Trust |
Epidemic Preparedness: COVID-19 Funding Call |
up to £2,000,000 |
closed to high level of interest |
| White House Office of Science & Technology |
COVID-19 High Performance Computing Consortium (Xsede) |
Computing Resources |
effective immediately |
| XPRIZE |
2020 COVID-19 Call for Code Global Challenge |
$270,000 |
7/31/2020 |
